Extracellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC).

被引：0
|
作者：
Basin, Michael
Jacob, Joseph M.
Bratslavsky, Gennady
Grivas, Petros
Spiess, Philippe E.
Li, Roger
Necchi, Andrea
Pavlick, Dean C.
Huang, Richard S. P.
Lin, Douglas I.
Danziger, Natalie
Sokol, Ethan
Sivakumar, Smruthy
Ross, Jeffrey S.
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY USA
[2] Univ Washington, Div Oncol, Dept Med,Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] IRCCS San Raffaele Hosp & Sci Inst, Dept Med Oncol, Milan, Italy
[6] Fdn Med Inc, Cambridge, MA USA
[7] Fdn Med Inc, Morrisville, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Y Meng
    L Zheng
    Y Yang
    H Wang
    J Dong
    C Wang
    Y Zhang
    X Yu
    L Wang
    T Xia
    D Zhang
    Y Guo
    B Li
    Oncogenesis, 2016, 5 : e211 - e211
  • [32] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Meng, Y.
    Zheng, L.
    Yang, Y.
    Wang, H.
    Dong, J.
    Wang, C.
    Zhang, Y.
    Yu, X.
    Wang, L.
    Xia, T.
    Zhang, D.
    Guo, Y.
    Li, B.
    ONCOGENESIS, 2016, 5 : e211 - e211
  • [33] Identification of a novel EGFR sparing brain penetrant ErbB2 inhibitor with activity against oncogenic ErbB2 mutations
    Chicarelli, Mark J.
    Bouhana, Karyn
    Brizendine, Richard K.
    Cable, LouAnn
    Crow, Michelle
    Fell, Brad
    Fischer, John
    Fulton, Jennifer
    Guarnieri, Anna
    Jalluri, Ravi
    Knox, Hailey
    Koch, Keith A.
    Rieger, Rob
    Robinson, John
    Stunkard, Lee M.
    Sullivan, Francis
    Turton, Roy
    Winski, Shannon
    Zhou, Yeyun
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells
    Pero, SC
    Shukla, GS
    Armstrong, AL
    Peterson, D
    Fuller, SP
    Godin, K
    Kingsley-Richards, SL
    Weaver, DL
    Bond, J
    Krag, DN
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) : 951 - 960
  • [35] Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2–ErbB3 complex in their active conformations
    Juan Felipe Franco-Gonzalez
    Javier Ramos
    Victor L. Cruz
    Javier Martínez-Salazar
    Journal of Molecular Modeling, 2013, 19 : 931 - 941
  • [36] Genomic Landscape and Clinical Features of Carcinomas with ERBB2 S310 Extracellular Domain Mutations
    Desmeules, Patrice
    Zehir, Ahmet
    Hyman, David M.
    Arcila, Maria E.
    LABORATORY INVESTIGATION, 2017, 97 : 456A - 456A
  • [37] A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.
    Wang, Kai
    Ross, Jeff S.
    Gay, Laurie M.
    Al-Rohil, Rami N.
    Nazeer, Tipu
    Sheehan, Christine E.
    Jennings, Timothy A.
    Otto, Geoff A.
    Donahue, Amy
    He, Jie
    Palmer, Gary
    Ali, Siraj
    Nahas, Michelle
    Young, Geneva
    LaBrecque, Elaine
    Frampton, Garrett
    Erlich, Rachel
    Curran, John A.
    Brennan, Tina
    Downing, Sean R.
    Yelensky, Roman
    Lipson, Doron
    Hawryluk, Matthew J.
    Miller, Vincent A.
    Stephens, Philip J.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [38] In vivo identification of the interaction site of ErbB2 extracellular domain with its autoinhibitor
    Hu, PL
    Feng, JN
    Zhou, T
    Wang, JN
    Jing, BF
    Yu, M
    Hu, MR
    Zhang, XM
    Shen, BF
    Guo, N
    JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 205 (03) : 335 - 343
  • [39] ERBB2 hangs in the balance
    Anna S. Kushnir
    Nature Reviews Cancer, 2009, 9 : 12 - 13
  • [40] ERBB2 hangs in the balance
    Kushnir, Anna S.
    NATURE REVIEWS CANCER, 2009, 9 (01) : 12 - 12
12345